Malignant Reproductive System Neoplasm — Trials

Malignant Reproductive System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

12,155 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,803
Recruiting: 1,544
Ph III recruiting: 175
Growth YoY: +16.5%
Industry share: 21%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 27.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,473)

clinicaltrialsPublishedShowing 51–100 of 12,155 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03762733	Tissue Acquisition and Genomics Analysis of Breast Cancer and Other Gynecologic Malignancies	enrolling by invitation	—	500	National Cancer Institute (NCI)NIH	1	Sep 28, 2026	clinicaltrials
NCT04065009	The IPLA-OVCA Trial, Intra-Peritoneal Local Anaesthetics in Ovarian Cancer(IPLA-OVCA)	active not recruiting	Phase 3	220	Karolinska InstitutetOTHER	1	Sep 28, 2026